首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1386603

克隆和诱变市场报告：2030 年趋势、预测和竞争分析

Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月12日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

克隆和诱变趋势和预测

到 2030 年，全球克隆和诱变市场预计将达到 70 亿美元，2024 年至 2030 年年复合成长率为 18.0%。该市场的主要驱动力是慢性病和遗传疾病的日益普及、克隆和诱变技术的日益采用以及对个人化医疗的需求不断增长。全球克隆和诱变市场的未来前景广阔，为生物製药和製药公司、CRO和CMO以及学术和研究机构市场提供了机会。

克隆和诱变市场洞察

Lucintel 预测，由于克隆套件在基因治疗、遗传分析和生物製药等广泛应用中的采用不断增加，因此在预测期内克隆试剂盒将继续占据很大一部分。

由于疾病盛行率不断增加，生物製药和製药公司将继续成为该市场的最大细分市场。

由于对生物技术的需求不断增加以及主要企业的存在，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

宏观经济趋势（2018-2023）与预测（2024-2030）
全球克隆和诱变市场趋势（2018-2023）和预测（2024-2030）
按产品分類的全球克隆和诱变市场
- 克隆套件
- 诱变试剂套件
- 其他的
按技术分類的全球克隆和诱变市场
- 拓朴PCR克隆
- 平端克隆
- 无缝克隆
- 其他的
按最终用途分類的全球克隆和诱变市场
- 生物製药和製药公司
- 合约研究官（CRO）和首席行销长（CMO）
- 学术研究所

第4章2018-2030年分地区市场趋势及预测分析

按地区分類的全球克隆和诱变市场
北美克隆和诱变市场
欧洲克隆和诱变市场
亚太克隆与诱变市场
其他区域克隆和诱变市场

第5章竞争分析

产品系列分析
营运整合
波特五力分析

第6章成长机会与策略分析

成长机会分析
- 按产品分類的全球克隆和诱变市场成长机会
- 全球克隆和诱变市场的技术成长机会
- 按最终用途分類的全球克隆和诱变市场成长机会
- 按地区分類的全球克隆和诱变市场成长机会
全球克隆和诱变市场的新兴趋势
战略分析
- 新产品开发
- 扩大全球克隆和诱变市场的产能
- 全球克隆和诱变市场的合併、收购和合资企业
- 认证和许可

第7章主要企业概况

Takara Bio
Agilent Technologies
Thermo Fisher Scientific
New England Biolabs
Merck
Promega
Bio-Rad Laboratories
Danaher
Jena Bioscience
Assay Genie

简介目录

Cloning and Mutagenesis Trends and Forecast

The future of the global cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets. The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030 with a CAGR of 18.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Cloning and Mutagenesis by Segment

The study includes a forecast for the global cloning and mutagenesis by product, technology, end use, and region.

Cloning and Mutagenesis Market by Product [Shipment Analysis by Value from 2018 to 2030]:

Cloning Kits
Mutagenesis Kits
Others

Cloning and Mutagenesis Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

Topo PCR Cloning
Blunt end Cloning
Seamless Cloning
Others

Cloning and Mutagenesis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

Cloning and Mutagenesis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Cloning and Mutagenesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cloning and mutagenesis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cloning and mutagenesis companies profiled in this report include-

Takara Bio
Agilent Technologies
Thermo Fisher Scientific
New England Biolabs
Merck
Promega
Bio-Rad Laboratories
Danaher
Jena Bioscience
Assay Genie

Cloning and Mutagenesis Market Insights

Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Within this market, biopharmaceutical & pharmaceutical companies will remain the largest segment due to increasing prevalence of diseases.

North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Features of the Global Cloning and Mutagenesis Market

Market Size Estimates: Cloning and mutagenesis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cloning and mutagenesis market size by product, technology, end use, and region in terms of value ($B).

Regional Analysis: Cloning and mutagenesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end uses, and regions for the cloning and mutagenesis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cloning and mutagenesis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cloning and mutagenesis market size?

Answer: The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030.

Q.2 What is the growth forecast for cloning and mutagenesis market?

Answer: The global cloning and mutagenesis market is expected to grow with a CAGR of 18.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cloning and mutagenesis market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

Q4. What are the major segments for cloning and mutagenesis market?

Answer: The future of the cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets.

Q5. Who are the key cloning and mutagenesis market companies?

Answer: Some of the key cloning and mutagenesis companies are as follows:

Takara Bio
Agilent Technologies
Thermo Fisher Scientific
New England Biolabs
Merck
Promega
Bio-Rad Laboratories
Danaher
Jena Bioscience
Assay Genie

Q6. Which cloning and mutagenesis market segment will be the largest in future?

Answer: Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Q7. In cloning and mutagenesis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the cloning and mutagenesis market by product (cloning kits, mutagenesis kits, and others), technology (topo PCR cloning, blunt end cloning, seamless cloning, and others), end use (biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Cloning and Mutagenesis Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cloning and Mutagenesis Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cloning and Mutagenesis Market by Product
- 3.3.1: Cloning Kits
- 3.3.2: Mutagenesis Kits
- 3.3.3: Others
3.4: Global Cloning and Mutagenesis Market by Technology
- 3.4.1: Topo PCR Cloning
- 3.4.2: Blunt end Cloning
- 3.4.3: Seamless Cloning
- 3.4.4: Others
3.5: Global Cloning and Mutagenesis Market by End Use
- 3.5.1: Biopharmaceutical & Pharmaceutical Companies
- 3.5.2: CROs & CMOs
- 3.5.3: Academic & Research Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Cloning and Mutagenesis Market by Region
4.2: North American Cloning and Mutagenesis Market
- 4.2.2: North American Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
4.3: European Cloning and Mutagenesis Market
- 4.3.1: European Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
- 4.3.2: European Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
4.4: APAC Cloning and Mutagenesis Market
- 4.4.1: APAC Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
- 4.4.2: APAC Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
4.5: ROW Cloning and Mutagenesis Market
- 4.5.1: ROW Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
- 4.5.2: ROW Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Cloning and Mutagenesis Market by Product
- 6.1.2: Growth Opportunities for the Global Cloning and Mutagenesis Market by Technology
- 6.1.3: Growth Opportunities for the Global Cloning and Mutagenesis Market by End Use
- 6.1.4: Growth Opportunities for the Global Cloning and Mutagenesis Market by Region
6.2: Emerging Trends in the Global Cloning and Mutagenesis Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Cloning and Mutagenesis Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cloning and Mutagenesis Market
- 6.3.4: Certification and Licensing